ArticleCurrent issues in molecular biology2023

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4.

Daniel V Kalinovsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.